Adagene Inc.ADAG

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$2.93
Market cap
$173.6M
P/E
—
Revenue (FY)
$7.7M
Net income
-$17.6M
Dividend yield
—
1-year total return
45.0%
Net margin
-229.6%
Revenue growth
7332.8%
Debt / equity
0.17x

What Adagene Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$700,913$10.2M$9.3M$18.1M$103,204$7.7M
Net income-$42.4M-$73.2M-$80.0M-$18.9M-$33.4M-$17.6M
Free cash flow-$29.5M-$45.9M-$49.3M-$28.5M-$29.7M-$15.7M

More on ADAG.

Figures from Adagene Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.